Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $2.19 (203.82% upside)

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015MLV & Co.Initiated CoverageBuy$1.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2015ZacksDowngradeOutperform -> Neutral$1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2014ZacksUpgradeNeutral -> Outperform$0.80View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014LaidlawInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Brinson PatrickInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2014Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)